StockData
Telomir Pharmaceuticals, Inc. logo

Telomir Pharmaceuticals, Inc. (TELO) stock

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.42−0.00 (-0.61%)

Close on Nov 18, 2026Market cap $28.92MP/E –Yield –

Telomir Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Telomir Pharmaceuticals

Telomir Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Telomir Pharmaceuticals figures

See a number that looks wrong?